These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 776861)

  • 1. Production of anti-M. leprae antibodies in man and mice under the impairment of cell mediated immunity.
    Abe M; Minagawa F; Yoshino Y; Ozawa T; Saito N
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):234-42. PubMed ID: 776861
    [No Abstract]   [Full Text] [Related]  

  • 2. Does the suppression of the immune response in pre-clinical lepromatous leprosy affect both cell-mediated and humoral responses in Mycobacterium leprae antigens?
    Stoner GL
    Lepr Rev; 1981 Mar; 52(1):102-3. PubMed ID: 7017316
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible roles of anti-Mycobacterium leprae antibodies in suppression of the cell-mediated immune response against M. leprae.
    Parkash O; Sengupta U
    Immunol Today; 1992 Dec; 13(12):513. PubMed ID: 1463585
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
    Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation of in vitro lymphocyte responses to M. leprae antigen in borderline tuberculoid leprosy patients.
    Bjune G
    Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):30-40. PubMed ID: 6154019
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sequential activation of cellular and humoral immunity in leprosy: considerations based on recent findings].
    Rojas-Espinosa O; Jiménez-Zamudio L; Arce-Paredes P
    Rev Latinoam Microbiol; 1994; 36(3):213-9. PubMed ID: 7709098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of non-conventional antigen: M. habana in detecting M. leprae antibodies from leprosy patients and contacts in FLA-ABS test.
    Rana NS; Gupta HP; Singh NB
    Indian J Lepr; 1988 Oct; 60(4):593-9. PubMed ID: 3075637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Change in cell-mediated immunity to Mycobacterium leprae and Mycobacterium marinum in Hansen's disease patients].
    Fliess EL; Ortiz MC; Corn J
    Hansenol Int; 1983 Jun; 8(1):9-17. PubMed ID: 6432692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended studies on subclinical infection in leprosy.
    Bharadwaj VP; Ramu G; Desikan KV; Katoch K
    Indian J Lepr; 1984; 56(4):807-12. PubMed ID: 6398341
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-M. leprae antibodies and the serology of leprosy].
    Bach MA
    Acta Leprol; 1986; (102):331-41. PubMed ID: 2436432
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibodies against Mycobacterium leprae antigen 7 from birth to 18 months of age: an indicator of intra-uterine infection in leprosy.
    Melsom R; Duncan ME; Harboe M; Bjune G
    Clin Exp Immunol; 1980 Oct; 42(1):107-13. PubMed ID: 7006873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of immune complexes in alteration of lymphocyte subpopulation numbers and functions in experimental leprosy.
    Vaishnavi C; Kaur S; Kumar B; Ganguly NK
    Indian J Lepr; 1987; 59(4):452-61. PubMed ID: 3330555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A follow up of T-cell subsets and of anti-M. leprae antibody titer as measured by the FLA-ABS test in Melanesian leprosy patients under polychemotherapy.
    Garraud O; Ribierre O; Bach MA
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):38-45. PubMed ID: 2940306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA, IgM and IgG anti-M. leprae antibodies in babies of leprosy mothers during the first 2 years of life.
    Melsom R; Harboe M; Duncan ME
    Clin Exp Immunol; 1982 Sep; 49(3):532-42. PubMed ID: 6756719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunogenetics of leprosy].
    Lagrange PH
    Acta Leprol; 1986; 4(3):303-22. PubMed ID: 3551470
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunology and the changing profile of leprosy.
    Job CK
    Lepr India; 1978 Apr; 50(2):214-30. PubMed ID: 353384
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunity to leprosy. 1. The proliferative response of murine T lymphocytes to Mycobacterium leprae.
    Douglas-Jones AG; Watson JD
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):412-20. PubMed ID: 3900249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis.
    Brett SJ; Draper P; Payne SN; Rees RJ
    Clin Exp Immunol; 1983 May; 52(2):271-9. PubMed ID: 6407793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between titers of antibodies immunoreacting against glycolipid antigens from Mycobacterium leprae and M. tuberculosis, the Mitsuda and Mantoux reactions, and bacteriological loads: implications in the pathogenesis, epidemiology and serodiagnosis of leprosy and tuberculosis.
    David HL; Papa F; Cruaud P; Berlie HC; Maroja MF; Salem JI; Costa MF
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):208-24. PubMed ID: 1522363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.